Title:
PHARMACEUTICAL USE OF β2-MICROGLOBULIN OR INHIBITOR THEREOF
Document Type and Number:
WIPO Patent Application WO/2022/262624
Kind Code:
A1
Abstract:
The present invention belongs to the field of biomedicine, and relates to a pharmaceutical use of β2-microglobulin or an inhibitor thereof. In particular, the present invention relates to a use of β2-microglobulin or an inhibitor thereof in preparing a medicine for the treatment and/or prevention of Down's syndrome or Alzheimer's disease. β2-microglobulin can be used as an effective drug target for the prevention and treatment of Down's syndrome or Alzheimer's disease.
More Like This:
Inventors:
WANG XIN (CN)
GAO YUE (CN)
ZHAO YINI (CN)
ZHENG QIUYANG (CN)
ZHENG SHUANG (CN)
LANG MAOJU (CN)
GAO YUE (CN)
ZHAO YINI (CN)
ZHENG QIUYANG (CN)
ZHENG SHUANG (CN)
LANG MAOJU (CN)
Application Number:
PCT/CN2022/097744
Publication Date:
December 22, 2022
Filing Date:
June 08, 2022
Export Citation:
Assignee:
UNIV XIAMEN (CN)
International Classes:
A61K45/00; A61K39/395; A61P25/28
Domestic Patent References:
| WO2017127537A1 | 2017-07-27 |
Foreign References:
| IN2923CHN2008A | 2009-03-06 | |||
| EP1741781A2 | 2007-01-10 | |||
| CN111358778A | 2020-07-03 | |||
| EP1394549A1 | 2004-03-03 |
Other References:
DOMINICI ROBERTO, FINAZZI DARIO, POLITO LETIZIA, OLDONI EMANUELA, BUGARI GIOVANNA, MONTANELLI ALESSANDRO, SCARPINI ELIO, GALIMBERT: "2-microglobulin serum level between Alzheimer’s patients, cognitive healthy and mild cognitive impaired individuals", BIOMARKERS, TAYLOR AND FRANCIS, LONDON, GB, vol. 23, no. 6, 18 August 2018 (2018-08-18), GB , pages 603 - 608, XP093015693, ISSN: 1354-750X, DOI: 10.1080/1354750X.2018.1468825
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: